LDT Final Act? US FDA Will Not Appeal District Court Decision Vacating Final Rule

The US FDA ended efforts to regulate lab-developed tests as medical devices for now when it did not appeal a decision from the Eastern District of Texas that tossed out the agency's final rule.

FDA efforts to regulate LDTs have come to the end of the road, at least for now. (Shutterstock)

More from R&D

More from Pathways & Standards